News Just Out!
Romanian Institute of Oncology and thePasteur Institute in Bucharest Report Favorable Preliminary Results OnAging and Cancer Treatment From Steroidogenesis Inhibitors' ANTICORT Drug
June 2, 1999 02:36 PM
LAS VEGAS--(BW HealthWire)--June 2, 1999--Steroidogenesis Inhibitors International STGI today reported that the Romanian Institute of Oncology and the Pasteur Institute in Bucharest indicated favorable preliminary results on aging and cancer treatment from Steroidogenesis' ANTICORT(tm).
Dr. Nicolae Voiculetz, the lead scientist, interviewed in Bucharest's The Financial Journal, and other Romanian newspapers, reported that by using the drug ANTICORT(tm) on fibroblast cells grown on tissue cultures, there was an extension of their life by 75%. Dr. Voiculetz said that these results, while preliminary, brought important information not only about the aging process, but in the field of cancer treatment.
ANTICORT is STGI's flagship anticortisol drug developed to treat "high cortisol" diseases. It has been demonstrated that cortisol, a powerful immunosuppressive hormone, is the cause of diseases/symptoms of diseases, which can be treated successfully with anticortisol drugs. Diseases associated with "high" cortisol include depression, anorexia nervosa, high blood pressure (hypertension), gastrointestinal ulcers, myocardial infarction, diabetes, rheumatoid arthritis, infectious diseases (AIDS, viral hepatitis, recurrent herpes genitalis), multiple sclerosis (MS), Parkinson's, aging/Alzheimer's and cancers of breast, uterine and prostate.
This release may include "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable it can give no assurance that such expectations will prove correct. This is neither an offer to buy or sell a security. For informational purposes only, from sources deemed to be reliable. For more information visit our World Wide Web page at www.anticort.com. |
